Full video transcriptClick to expand
Auto-generated transcript of @daviddemesquita's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00The sleep peptide though will make you sleep for 10 plus hours even while blasting trend.
- 0:04DSIP I am losing credibility so let's jump into this. The first time I actually was a
- 0:09doing experiment it was a bunch of anotropic experience in my final bodybuilding prep.
- 0:13DSIP was finally readily available so I decided to give it a shot. Unfortunately when I did my shot
- 0:19I took a little bit too much and by a little bit too much it wasn't even that much more. It was
- 0:23100 micrograms more than I found my sweet spot was and my theory behind it was it was just going
- 0:31to force me into REM state of sleep. Well what I found out is that it didn't just force me into
- 0:37REMs I would sometimes wake up dreaming literally dreaming with my eyes open and realize I was like
- 0:42oh I need a peanut and I would get up out of bed and go to the bathroom. So yeah sleeping 10 and
- 0:47half hours and I find that this peptide in general is successful for around 98% of people that I use
- 0:54it for and my sweet spot and most people sweet spot is between 300 micrograms per day up to 400
- 0:59micrograms per day. Now when I did sleep the 10 and a half hours I actually didn't need to make
- 1:04up some sleep but my theory was not that I would sleep longer it's that I would just get REM state
- 1:10of sleep. So if I'm losing credibility from offering advice that I found helpful to people
- 1:16then so be it.
Does poor sleep actually tank your testosterone during a cut?
Quick answer
The creator uses DSIP, an unregulated research peptide with limited and inconsistent human trial data, as a self-administered sleep aid during a bodybuilding preparation phase that also involves trenbolone, a potent anabolic steroid associated with significant sleep disruption. Any sleep outcomes observed in this context are impossible to attribute to DSIP alone, given the number of uncontrolled variables including anabolic steroid use, caloric restriction, and training load. There is no FDA-approved use for DSIP, no established human dosing protocol, and no regulated manufacturing standard governing its quality or concentration.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 7 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Does poor sleep actually tank your testosterone during a cut?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Does poor sleep actually tank your testosterone during a cut? should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Does poor sleep actually tank your testosterone during a cut?" from David DeMesquita™️. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator uses DSIP, an unregulated research peptide with limited and inconsistent human trial data, as a self-administered sleep aid during a bodybuilding preparation phase that also involves trenbolone, a potent anabolic steroid associated with significant sleep disruption.
The reason this review is not generic is the source wording and the canonical claim label "trt replying to raffi625 sleep is extremely critical to getting." In this clip, the useful excerpt is: "The sleep peptide though will make you sleep for 10 plus hours even while blasting trend." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator uses DSIP, an unregulated research peptide with limited and inconsistent human trial data, as a self-administered sleep aid during a bodybuilding preparation phase that also involves trenbolone, a potent anabolic steroid associated with significant sleep disruption.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator uses DSIP, an unregulated research peptide with limited and inconsistent human trial data, as a self-administered sleep aid during a bodybuilding preparation phase that also involves trenbolone, a potent anabolic steroid associated with significant sleep disruption. Any sleep outcomes observed in this context are impossible to attribute to DSIP alone, given the number of uncontrolled variables including anabolic steroid use, caloric restriction, and training load. There is no FDA-approved use for DSIP, no established human dosing protocol, and no regulated manufacturing standard governing its quality or concentration.
- DSIP was first isolated in 1974 and showed early promise in animal models, but human clinical trials produced inconsistent results and no FDA-approved therapeutic use has ever been established.
- The primary sleep-stage association in early DSIP research was with slow-wave (non-REM) sleep, not REM sleep as the creator claims, based on Monnier et al. (1979, Pharmacology Biochemistry and Behavior).
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- DSIP was first isolated in 1974 and showed early promise in animal models, but human clinical trials produced inconsistent results and no FDA-approved therapeutic use has ever been established.
- The primary sleep-stage association in early DSIP research was with slow-wave (non-REM) sleep, not REM sleep as the creator claims, based on Monnier et al. (1979, Pharmacology Biochemistry and Behavior).
- Trenbolone is independently documented to disrupt sleep architecture, making any sleep outcome observed while using both compounds unattributable to DSIP alone.
- A '98% success rate' reported by someone administering an uncontrolled, unblinded intervention to clients is not a clinical statistic and should not be treated as one.
- DSIP degrades rapidly in plasma after injection, and Graf and Kastin (1984, Neuroscience and Biobehavioral Reviews) noted this as a major barrier to reliable CNS delivery and reproducible effects.
- Cognitive behavioral therapy for insomnia (CBT-I) has stronger long-term evidence for sleep improvement than any peptide currently sold in unregulated research markets, per Trauer et al. (2015, Annals of Internal Medicine).
- DSIP is sold without regulated manufacturing standards in the U.S., meaning purity and concentration accuracy cannot be assumed from any commercial source.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @daviddemesquita actually say?
The creator claims that DSIP (delta sleep-inducing peptide) is a reliable sleep aid that works for "98% of people" he's used it with, that a personal sweet spot of 300-400 micrograms per day is broadly applicable, and that taking slightly too much (100 micrograms over his threshold) caused him to wake up actively dreaming, a phenomenon sometimes associated with REM sleep disruption. He also claims it can sustain sleep "10 plus hours even while blasting tren," referencing trenbolone, a powerful anabolic steroid.
The self-deprecating framing, "I am losing credibility," doesn't soften the fact that he's offering specific dosing guidance based entirely on personal experimentation. That matters, because DSIP has a thin clinical research record and essentially no regulated medical use in humans in the United States.
Does the science back this up?
Barely, and not in the way the creator implies. DSIP was first isolated in 1974 and generated real interest through the 1980s, but that interest largely faded because human trials produced inconsistent, context-dependent results.
The original work by Schoenenberger and colleagues (1977, Pflügers Archiv) described DSIP as a neuromodulator that could alter sleep architecture in rabbits. Subsequent human studies, including a small trial by Monnier et al. (1979, Pharmacology Biochemistry and Behavior), suggested it might reduce sleep latency and increase slow-wave sleep under specific conditions. However, a later review by Graf and Kastin (1984, Neuroscience and Biobehavioral Reviews) noted that results were highly variable and dependent on baseline sleep quality, peptide stability, and route of administration. DSIP degrades rapidly in plasma, which makes subcutaneous injection an unreliable delivery method for consistent CNS effects. The creator's anecdote about sleeping 10.5 hours is plausible in isolation, but attributing it specifically to DSIP's REM-forcing properties goes beyond what the literature supports.
What did they get wrong (or right)?
He got the basic concept half-right. DSIP does appear to influence sleep architecture, particularly slow-wave sleep, in some research contexts. His observation that taking more didn't just deepen sleep but created something closer to a dissociative, dreaming-while-awake experience is actually worth noting. That kind of experience is loosely consistent with REM intrusion or hypnopompic hallucination, not just "forced REM" as he frames it.
What he got wrong is more significant. First, the "98% success rate" is a fabricated statistic. He has no controls, no comparative group, and no way to isolate DSIP's effect from placebo, lifestyle changes, or other compounds in his clients' stacks. Second, presenting 300-400 micrograms as a general population sweet spot is irresponsible. There is no peer-reviewed human dosing protocol for DSIP. Third, using DSIP while also using trenbolone, a compound known to cause severe sleep disruption and androgenic side effects, means any reported sleep benefit is confounded to the point of being uninterpretable. Attributing sleep improvement to DSIP in that context is guesswork dressed as insight.
What should you actually know?
DSIP is not approved by the FDA for any therapeutic use. It is sold in research markets and compounded peptide suppliers, which means purity, concentration accuracy, and sterility are not guaranteed. The clinical history is real but limited, and most of the promising early data never translated into human clinical trials robust enough to establish safety or dosing standards.
If you're dealing with sleep issues related to hormonal therapy or bodybuilding compounds, that is a legitimate clinical problem worth addressing. There are evidence-based options including cognitive behavioral therapy for insomnia (CBT-I), which multiple meta-analyses, including Trauer et al. (2015, Annals of Internal Medicine) show outperforms sleep medications in long-term outcomes. Melatonin, magnesium glycinate, and addressing the underlying hormonal disruption with a licensed provider are also grounded options. Injecting an unregulated peptide based on a TikTok creator's personal dose experimentation is not a risk-neutral decision, regardless of how honest he sounds about it.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
David DeMesquita™️ · TikTok creator
9.6K views on this video
Replying to @Raffi625 sleep is extremely critical to getting in shape in prep #bodybuilding #trt #biohacking #sleep
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about dsip was first?
DSIP was first isolated in 1974 and showed early promise in animal models, but human clinical trials produced inconsistent results and no FDA-approved therapeutic use has ever been established.
What does the video say about the primary sleep-stage association in early dsip research was with?
The primary sleep-stage association in early DSIP research was with slow-wave (non-REM) sleep, not REM sleep as the creator claims, based on Monnier et al. (1979, Pharmacology Biochemistry and Behavior).
What does the video say about trenbolone?
Trenbolone is independently documented to disrupt sleep architecture, making any sleep outcome observed while using both compounds unattributable to DSIP alone.
What does the video say about a '98% success rate' reported by someone administering an uncontrolled,?
A '98% success rate' reported by someone administering an uncontrolled, unblinded intervention to clients is not a clinical statistic and should not be treated as one.
What does the video say about dsip degrades rapidly in plasma after injection,?
DSIP degrades rapidly in plasma after injection, and Graf and Kastin (1984, Neuroscience and Biobehavioral Reviews) noted this as a major barrier to reliable CNS delivery and reproducible effects.
What does the video say about cognitive behavioral therapy for insomnia (cbt-i) has stronger long-term evidence?
Cognitive behavioral therapy for insomnia (CBT-I) has stronger long-term evidence for sleep improvement than any peptide currently sold in unregulated research markets, per Trauer et al. (2015, Annals of Internal Medicine).
Sources & references
- [1]Monnier et al. (1979)
- [2]Trauer et al. (2015)
- [3]Schoenenberger and colleagues (1977)
- [4]Graf and Kastin (1984)
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by David DeMesquita™️, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.